𝔖 Bobbio Scriptorium
✦   LIBER   ✦

What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?

✍ Scribed by Capdevila, Jaume; Carrato, Alfredo; Tabernero, Josep; Grande, Enrique


Book ID
122209975
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
727 KB
Volume
92
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.